ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education
Diabetes Technology & Therapeutics · 2023-08 · 25 (8) · 571-573
DOI: 10.1089/dia.2023.0134 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 31.07.2023. Verfasst von Afif Nakhleh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrinology Clinic, Maccabi Healthcare Services, Haifa, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Themen: Diabetes mellitus, Künstliche Intelligenz in der Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Diabetes and Endocrinology Clinic, Maccabi Healthcare Services, Haifa, Israel.
- Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus, Haifa, Israel.
- The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Zitieren
APA
Nakhleh, A., Spitzer, S., & Shehadeh, N. (2023). ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education. Diabetes Technology & Therapeutics, 25(8), 571-573. https://doi.org/10.1089/dia.2023.0134
Vancouver
Nakhleh A, Spitzer S, Shehadeh N. ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education. Diabetes Technology & Therapeutics. 2023;25(8):571-573. doi:10.1089/dia.2023.0134
BibTeX
@article{Nakhleh2023,
author = {Nakhleh, Afif and Spitzer, Sivan and Shehadeh, Naim},
title = {ChatGPT's Response to the Diabetes Knowledge Questionnaire: Implications for Diabetes Education},
journal = {Diabetes Technology & Therapeutics},
year = {2023},
volume = {25},
number = {8},
pages = {571--573},
doi = {10.1089/dia.2023.0134}
}
EUVIMED